Gland Pharma Limited issued a Postal Ballot Notice seeking shareholder approval via remote e-voting for a special resolution.
The resolution proposes to reappoint Ms. Naina Lal Kidwai as an Independent Director for a second five-year term from May 17, 2026.
The resolution also seeks approval to pay her a commission of 0.25% on net profits, capped at INR 10 million annually for FY2027-2031.
The e-voting period runs from April 14, 2026, to May 13, 2026, with results to be announced on or before May 15, 2026.